Form 4 for IMUX IMMUNIC, INC.
Accepted 2023-05-16 00:00:00 ET · period of report 2023-05-15 · accession 0001193805-23-000735 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-16 | 2023-05-15 | IMUX | Whaley Glenn | CFO | P - Purchase | $1.75 | +5,000 | 25.5K | +24% | +$8,750 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-15 | P | A | 5,000 | $1.75 | 25,510 | D | — | — | (F1) Includes a purchase of 2,568 shares on 11/30/21 and 2,942 shares on 5/31/22 under the IMUX employee stock purchase plan. |